Shu Tadaka

2.4k total citations
27 papers, 1.0k citations indexed

About

Shu Tadaka is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Shu Tadaka has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Oncology. Recurrent topics in Shu Tadaka's work include Bioinformatics and Genomic Networks (9 papers), Gene expression and cancer classification (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Shu Tadaka is often cited by papers focused on Bioinformatics and Genomic Networks (9 papers), Gene expression and cancer classification (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Shu Tadaka collaborates with scholars based in Japan, United States and Norway. Shu Tadaka's co-authors include Kengo Kinoshita, Yuichi Aoki, Takeshi Obayashi, Yasunobu Okamura, Yuki Kagaya, Satoshi Ito, Matsuyuki Shirota, Ikuko N. Motoike, Masayuki Yamamoto and Takafumi Narise and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Bioinformatics.

In The Last Decade

Shu Tadaka

26 papers receiving 1.0k citations

Peers

Countries citing papers authored by Shu Tadaka

Since Specialization

Citations

This map shows the geographic impact of Shu Tadaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Tadaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Tadaka more than expected).

Fields of papers citing papers by Shu Tadaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Tadaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Tadaka. The network helps show where Shu Tadaka may publish in the future.

Co-authorship network of co-authors of Shu Tadaka

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Tadaka. A scholar is included among the top collaborators of Shu Tadaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Tadaka. Shu Tadaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional significance of CYP2B6 gene rare allelic variants identified in Japanese individuals 2024 ·Biochemical Pharmacology ·(unknown), Eiji Hishinuma, (unknown), Akiko Ueda, (unknown), Tomoki Nakayoshi, Akifumi Oda, Sakae Saito, Shu Tadaka, Kengo Kinoshita, Masamitsu Maekawa, (unknown), Masaki Kumondai, Nariyasu Mano, Noriyasu Hirasawa, Masahiro Hiratsuka	2
2	Identifying critical age and gender-based metabolomic shifts in a Japanese population of the Tohoku Medical Megabank cohort 2024 ·Scientific Reports ·(unknown), Ikuko N. Motoike, Eiji Hishinuma, Yuichi Aoki, Shu Tadaka, Mana Kogure, Masatsugu Orui, Mami Ishikuro, Taku Obara, Naoki Nakaya, Kazuki Kumada, Atsushi Hozawa, Shinichi Kuriyama, Masayuki Yamamoto, S. Koshiba, (unknown)	0
3	Two-stage strategy using denoising autoencoders for robust reference-free genotype imputation with missing input genotypes 2024 ·Journal of Human Genetics ·Kaname Kojima, Shu Tadaka, Yasunobu Okamura, Kengo Kinoshita	1
4	Functional Characterization of 29 Cytochrome P450 4F2 Variants Identified in a Population of 8380 Japanese Subjects and Assessment of Arachidonic Acid ω-Hydroxylation 2023 ·Drug Metabolism and Disposition ·(unknown), Eiji Hishinuma, (unknown), Akiko Ueda, Masaki Kumondai, Sakae Saito, Shu Tadaka, Kengo Kinoshita, Tomoki Nakayoshi, Akifumi Oda, Masamitsu Maekawa, Nariyasu Mano, Noriyasu Hirasawa, Masahiro Hiratsuka	3
5	Functional Characterization of 12 Dihydropyrimidinase Allelic Variants in Japanese Individuals for the Prediction of 5-Fluorouracil Treatment-Related Toxicity 2022 ·Drug Metabolism and Disposition ·Eiji Hishinuma, (unknown), (unknown), Akiko Ueda, (unknown), Yoshikazu Tanaka, Sakae Saito, Shu Tadaka, Kengo Kinoshita, Masamitsu Maekawa, Nariyasu Mano, Tomoki Nakayoshi, Akifumi Oda, Noriyasu Hirasawa, Masahiro Hiratsuka	1
6	Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population 2022 ·Frontiers in Pharmacology ·Eiji Hishinuma, (unknown), (unknown), Akiko Ueda, Sakae Saito, Shu Tadaka, Kengo Kinoshita, Masamitsu Maekawa, Nariyasu Mano, Noriyasu Hirasawa, Masahiro Hiratsuka	17
7	Construction of a trio-based structural variation panel utilizing activated T lymphocytes and long-read sequencing technology 2022 ·Communications Biology ·Akihito Otsuki, Yasunobu Okamura, N. Ishida, Shu Tadaka, Jun Takayama, Kazuki Kumada, Junko Kawashima, Keiko Taguchi, Naoko Minegishi, Shinichi Kuriyama, Gen Tamiya, Kengo Kinoshita, Fumiki Katsuoka, Masayuki Yamamoto	4
8	Pathological variants in genes associated with disorders of sex development and central causes of hypogonadism in a whole-genome reference panel of 8380 Japanese individuals 2022 ·Human Genome Variation ·(unknown), Yumi Yamaguchi‐Kabata, (unknown), Jun Yasuda, Shu Tadaka, (unknown), Zen Watanabe, Junko Kanno, Gen Tamiya, Nobuo Fuse, Kengo Kinoshita, Shigeo Kure, Akiko Kondo, Masahito Tachibana, Masayuki Yamamoto, Nobuo Yaegashi, Junichi Sugawara	1
9	Construction and integration of three de novo Japanese human genome assemblies toward a population-specific reference 2021 ·Nature Communications ·Jun Takayama, Shu Tadaka, Kenji Yano, Fumiki Katsuoka, (unknown), (unknown), Satoshi Makino, Yasunobu Okamura, Atsuo Kikuchi, (unknown), Junko Kawashima, Akihito Otsuki, Mika Sakurai‐Yageta, Jun Yasuda, Shigeo Kure, Kengo Kinoshita, Masayuki Yamamoto, Gen Tamiya	30
10	Estimation of the carrier frequencies and proportions of potential patients by detecting causative gene variants associated with autosomal recessive bone dysplasia using a whole-genome reference panel of Japanese individuals 2021 ·Human Genome Variation ·(unknown), Yumi Yamaguchi‐Kabata, (unknown), Masahito Tachibana, Jun Yasuda, Shu Tadaka, Gen Tamiya, Nobuo Fuse, Kengo Kinoshita, Shigeo Kure, Jun Murotsuki, Masayuki Yamamoto, Nobuo Yaegashi, Junichi Sugawara	2
11	Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2) 2021 ·PLoS ONE ·Hideki Tokunaga, (unknown), Atsushi Hozawa, Soichi Ogishima, Yoh Watanabe, Shogo Shigeta, Muneaki Shimada, Yumi Yamaguchi‐Kabata, Shu Tadaka, Fumiki Katsuoka, Shin Ito, Kazuki Kumada, Yohei Hamanaka, Nobuo Fuse, Kengo Kinoshita, Masayuki Yamamoto, Nobuo Yaegashi, Jun Yasuda	8
12	A genotype imputation method for de-identified haplotype reference information by using recurrent neural network 2020 ·PLoS Computational Biology ·Kaname Kojima, Shu Tadaka, Fumiki Katsuoka, Gen Tamiya, Masayuki Yamamoto, Kengo Kinoshita	14
13	Identification of critical genetic variants associated with metabolic phenotypes of the Japanese population 2020 ·Communications Biology ·S. Koshiba, Ikuko N. Motoike, Daisuke Saigusa, Jin Inoue, Yuichi Aoki, Shu Tadaka, Matsuyuki Shirota, Fumiki Katsuoka, Gen Tamiya, Naoko Minegishi, Nobuo Fuse, Kengo Kinoshita, Masayuki Yamamoto	19
14	Functional Characterization of 40 CYP3A4 Variants by Assessing Midazolam 1′-Hydroxylation and Testosterone 6β-Hydroxylation 2020 ·Drug Metabolism and Disposition ·Masaki Kumondai, (unknown), Eiji Hishinuma, Akiko Ueda, Sakae Saito, Daisuke Saigusa, Shu Tadaka, Kengo Kinoshita, Tomoki Nakayoshi, Akifumi Oda, (unknown), Masamitsu Maekawa, Nariyasu Mano, Noriyasu Hirasawa, Masahiro Hiratsuka	30
15	Estimating carrier frequencies of newborn screening disorders using a whole-genome reference panel of 3552 Japanese individuals 2019 ·Human Genetics ·Yumi Yamaguchi‐Kabata, Jun Yasuda, Akira Uruno, Kazuro Shimokawa, S. Koshiba, Yoichi Suzuki, Nobuo Fuse, Hiroshi Kawame, Shu Tadaka, Masao Nagasaki, Kaname Kojima, Fumiki Katsuoka, Kazuki Kumada, Osamu Tanabe, Gen Tamiya, Nobuo Yaegashi, Kengo Kinoshita, Masayuki Yamamoto, Shigeo Kure	6
16	jMorp: Japanese Multi Omics Reference Panel 2017 ·Nucleic Acids Research ·Shu Tadaka, Daisuke Saigusa, Ikuko N. Motoike, Jin Inoue, Yuichi Aoki, Matsuyuki Shirota, S. Koshiba, Masayuki Yamamoto, Kengo Kinoshita	72
17	ATTED-II in 2016: A Plant Coexpression Database Towards Lineage-Specific Coexpression 2015 ·Plant and Cell Physiology ·Yuichi Aoki, Yasunobu Okamura, Shu Tadaka, Kengo Kinoshita, Takeshi Obayashi	132
18	COXPRESdb in 2015: coexpression database for animal species by DNA-microarray and RNAseq-based expression data with multiple quality assessment systems 2014 ·Nucleic Acids Research ·Yasunobu Okamura, Yuichi Aoki, Takeshi Obayashi, Shu Tadaka, Satoshi Ito, Takafumi Narise, Kengo Kinoshita	124
19	ATTED-II in 2014: Evaluation of Gene Coexpression in Agriculturally Important Plants 2013 ·Plant and Cell Physiology ·Takeshi Obayashi, Yasunobu Okamura, Satoshi Ito, Shu Tadaka, Yuichi Aoki, Matsuyuki Shirota, Kengo Kinoshita	79
20	COXPRESdb: a database of comparative gene coexpression networks of eleven species for mammals 2012 ·Nucleic Acids Research ·Takeshi Obayashi, Yasunobu Okamura, Satoshi Ito, Shu Tadaka, Ikuko N. Motoike, Kengo Kinoshita	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact